Hemodynamic effects of myocardial bridging in patients with hypertrophic cardiomyopathy

Mohammadali Sharzehee1, Yuan Chang2, Jiang-Ping Song2

  • 1Department of Mechanical Engineering, The University of Texas at San Antonio, San Antonio, Texas.

Insights

Myocardial bridging (MB) significantly reduces coronary blood flow in hypertrophic cardiomyopathy (HCM) patients, causing diastolic disturbances. Severe MB compression (over 65%) indicates a need for surgical intervention in HCM patients.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Fluid Dynamics

Background:

  • Myocardial bridging (MB) is associated with angina, ischemia, and sudden cardiac death in hypertrophic cardiomyopathy (HCM) patients.
  • The impact of MB on coronary blood flow dynamics in HCM remains incompletely understood.

Purpose of the Study:

  • To assess the effects of MB on coronary hemodynamics in HCM patients.
  • To correlate hemodynamic findings with clinical outcomes for surgical decision-making.

Main Methods:

  • Transient computational fluid dynamics (CFD) simulations were performed on anatomically realistic models of the left anterior descending (LAD) coronary artery with and without MB.
  • Models were reconstructed from biplane angiograms of 15 patients (7 with HCM and MB, 8 non-HCM controls with MB).

Main Results:

  • Dynamic MB compression significantly reduced diastolic coronary flow and increased the pressure drop coefficient in HCM patients compared to controls (P < 0.01 and P < 0.05, respectively).
  • Flow rate changes correlated strongly with upstream Reynolds number and MB compression ratio; MB length had minimal impact.
  • HCM patients with an MB compression ratio >65% required surgical intervention.

Conclusions:

  • Transient MB compression alters diastolic flow patterns and wall shear stress distribution in HCM patients.
  • Severe MB, indicated by a compression ratio >65%, may necessitate surgical intervention in HCM patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
335
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
638
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.2K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
356
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
294
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
415